Archive

Abstract

Glaucoma is condition of increase intraocular pressure in the eye that may progress to a loss of vision. The optic is the main whim-whams that to the eye that's responsible for transmitting electrical signals to the brain. This damage generally occurs gradational visual changes and the loss of vision. Glaucoma can do in any age but is more common in aged grown-ups. In this review, we examined the pathophysiology and colorful threat factors of glaucoma.

Keywords

Intraocular pressure, blindness, glaucoma, optic nerve.

Reference

  1. Brunton L, Chabner B, Knollman B, Goodman & Gilman’s The Pharmacological base of cures, 12th edition, McGraw Hill medical, 2011, p- 1771- 801. 
  2. BalabathulaP.,JanagamD.R.,VuppalaP.K., Combination remedy in glaucoma treatment, Journal of clinical & experimental Pharmacology, 2013; 3( 3). 
  3. DadaT.,DaveV.,MithalN., Medical operation of glaucoma, Journal of current glaucoma practice, 2009; 3( 3); 13 – 17.   
  4. Deepak Sambhara et, al. Glaucoma operation relative value & place in remedy of available drug treatments. Ther Adv Chronic Dis.( 2014) 5( 1) 30- 43. 
  5. Glaucoma signs, treatment, order health tech. 2016. 
  6. KatzungB.G., Trevor A J, Basic & Clinical Pharmacology, 13th edition, McGraw Hill education 2015; 160- 1, 105.
  7. KhokharP.,ShuklaV., etal. optic drug delivery system, International Journal of Pharmaceutical Research & Review, 2014; 3.
  8. KhuranaA.K., Comprehensive Opthalmology, 6th edition, Jaypee sisters medical publishersLtd. 2015, p – 219- 5.
  9. P. Agrawal &S.E. Bradshaw, “ regular literature review of clinical & profitable issues ofmicro- invasive glaucoma surgery in primary open angle glaucoma ”, Ophthalmology & Therapy,vol. 7,no. 1, p- 49- 73, 2018. 
  10. RangH.P.,RitterJ.M., Flower R.J. & Henderson G., Rang & Dales Pharmacology, 8th edition Elsevier Ltd., 2016; 162- 3.
  11. S.K. Gupta, Recent advances in pharmacotherapy of Glaucoma, Indian Journal of Pharmacology, 2008. 
  12. Schwartz K., Budenz D., Current operation of glaucoma, Journal of current opinion ophthalmology, 2004; 15 119- 26. 
  13. Signs, symptoms;www.mayoclinic.org, 2015
  14. TripathiK.D., rudiments of Medical Pharmacology, 7th edition, Jaypee sisters medicalpublishersPvt.Ltd., 2013, 151- 7
  15. For drugs status ( https//adisinsight.springer.com/drugs) 
  16. For various trial details( https//clinicaltrials.gov) 
  17. WeinrebR.N,KhawP.T. Primary open- angle glaucoma. Lancet. 2004; 363( 9422) 1711 – 1720. 
  18. SathyamangalamR.V,PaulP.G., George R, et al. Determinants of glaucoma awareness and knowledge in communal Chennai. Indian J Ophthalmol. 2009; 57( 5) 355 – 360. 
  19. 19)Heijl A, Bengtsson B, Hyman L, Leske MC., Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology. 2009 Dec;116(12):2271-6.
  20. Arora T, Bali SJ, Arora V, Wadhwani M, Panda A, Dada T. Diurnal versus office-hour intraocular pressure fluctuation in primary adult onset glaucoma. J Optom. 2015 Oct-Dec;8(4):239-43.
  21. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980 May-Jun;24(6):621-64. 
  22. Drance SM, Sweeney VP, Morgan RW, Feldman F. Factors involved in the production of low tension glaucoma. Can J Ophthalmology. 1974 Oct;9(4):399-403. 
  23. Jonas JB, Fernández MC, Stürmer J. Pattern of glaucomatous neuroretinal rim loss. Ophthalmology. 1993 Jan;100(1):63-8. 
  24. Moghimi S, Ramezani F, He M, Coleman AL, Lin SC. Comparison of Anterior Segment-Optical Coherence Tomography Parameters in Phacomorphic Angle Closure and Acute Angle Closure Eyes. Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7611-7. 
  25. Thomas R, George R, Parikh R, Muliyil J, Jacob A. Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study. Br J Ophthalmol. 2003 Apr;87(4):450-4. 
  26. Craven ER, Katz LJ, Wells JM, Giamporcaro JE., iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012 Aug;38(8):1339-45. 
  27. Anderson DR., Normal Tension Glaucoma Study. Collaborative normal tension glaucoma study. Curr Opin Ophthalmol. 2003 Apr;14(2):86-90. 
  28. Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle-closure glaucoma: an update. Acta Ophthalmol. 2016 May;94(3):217-25. 
  29. Bai HQ, Yao L, Wang DB, Jin R, Wang YX. Causes and treatments of traumatic secondary glaucoma. Eur J Ophthalmol. 2009 Mar-Apr;19(2):201-6.
  30. Leibowitz HM. The red eye. N Engl J Med. 2000 Aug 03;343(5):345-51. 
  31. Greenfield DS. Glaucomatous versus nonglaucomatous optic disc cupping: clinical differentiation. Semin Ophthalmol. 1999 Jun;14(2):95-108. 
  32. Pasol J. Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes. Curr Opin Ophthalmol. 2011 Mar;22(2):124-32. 
  33. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol. 2006 Jun;124(6):853-9. 
  34. Pel?i? G, Ljubi?i? R, Bara? J, Biuk D, Rogoi? V. Glaucoma, depression and quality of life: multiple comorbidities, multiple assessments and multidisciplinary plan treatment. Psychiatr Danub. 2017 Sep;29(3):351-359. 
  35. Gallo Afflitto G, Aiello F, Cesareo M, Nucci C. Primary Open Angle Glaucoma Prevalence in Europe: A Systematic Review and Meta-Analysis. J Glaucoma. 2022 Oct 01;31(10):783-788. 
  36. Singh K, Bhushan P, Mishra D, Kaur K, Gurnani B, Singh A, Pandey S. Assessment of optic disk by disk damage likelihood scale staging using slit-lamp biomicroscopy and optical coherence tomography in diagnosing primary open-angle glaucoma. Indian J Ophthalmol. 2022 Dec;70(12):4152-4157. 
  37. Ezinne NE, Shittu O, Ekemiri KK, Kwarteng MA, Tagoh S, Ogbonna G, Mashige KP. Visual Impairment and Blindness among Patients at Nigeria Army Eye Centre, Bonny Cantonment Lagos, Nigeria. Healthcare (Basel). 2022 Nov 18;10(11).
  38. Parab A, Kavitha S, Odayappan A, Venkatesh R. Clinical and demographic profile of patients less than 40 years of age presenting to glaucoma services at a tertiary care eye hospital in South India. Indian J Ophthalmol. 2022 Dec;70(12):4186-4192. 
  39. Wagner IV, Stewart MW, Dorairaj SK. Updates on the Diagnosis and Management of Glaucoma. Mayo Clin Proc Innov Qual Outcomes. 2022 Dec;6(6):618-635. 
  40. Foster PJ, Luben R, Khawaja AP. Association, Risk, and Causation-Examining the Role of Systemic Medications in the Onset of Acute Angle-Closure Episodes. JAMA Ophthalmol. 2022 Nov 01;140(11):1064-1065. 
  41. Xu KM, Cho R, Chan TYB. Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension. Clin Ophthalmol. 2022;16:2385-2390. 
  42. Gosling D, Meyer JJ. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Dec 12, 2022. Normal Tension Glaucoma.
  43. Mahabadi N, Foris LA, Tripathy K. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 22, 2022. Open Angle Glaucoma. 
  44. Khazaeni B, Khazaeni L. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jan 2, 2023. Acute Closed Angle Glaucoma. 
  45. Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye (Lond). 1999 Oct;13 ( Pt 5):613-6. 
  46. POSNER A, SCHLOSSMAN A. Further observations on the syndrome of glaucomatocyclitic crises. Trans Am Acad Ophthalmol Otolaryngol. 1953 Jul-Aug;57(4):531-6. 
  47. Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR., Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013 Dec;1(6):e339-49.

Photo
Namrata S. Revar
Corresponding author

Department of Pharmaceutical Chemistry, Mahavir Institute of Pharmacy, Varvandi road, Mhasrul, Nashik.

Photo
Sanjeevani D. Rupwate
Co-author

Department of Pharmaceutical Chemistry, Mahavir Institute of Pharmacy, Varvandi road, Mhasrul, Nashik.

Photo
Samruddhi B. Sawant
Co-author

Department of Pharmaceutical Chemistry, Mahavir Institute of Pharmacy, Varvandi road, Mhasrul, Nashik.

Photo
Sanjana S. Shinde
Co-author

Department of Pharmaceutical Chemistry, Mahavir Institute of Pharmacy, Varvandi road, Mhasrul, Nashik.

Photo
Sanskruti Malode
Co-author

Department of Pharmaceutical Chemistry, Mahavir Institute of Pharmacy, Varvandi road, Mhasrul, Nashik.

Namrata S. Revar*, Sanjeevani D. Rupwate, Samruddhi B. Sawant, Sanjana S. Shinde, An Overview On Glaucoma: Silent Thief Of Sight, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 9, 361-369. https://doi.org/10.5281/zenodo.8352579

More related articles
Overview of Regulatory Guidelines for Stability st...
Parag Mangilal Lalwani , R. B. Darade, ...
Review On : Orphan Diseases And Treatment...
Shweta P. Manapure, Jayshree R. Khade, Vaibhav P. Uplanchiwar, Vi...
Basic Chemistry,Mode Of Action And Clinical Uses O...
Prashant Dattatray waghchaure , Trupti Thange, Vishal Gaikwad, ...
New Breakthrough In Cancer Treatment, Dostarlimab...
C. Sindhu, A. Srinivas Rao, A. V. Kishore Babu , ...
Overview On The Novel Medication Of Liquisolid Technology For Improving Solubili...
Desai Avni P., Krishna P. Vairagi, Dhruvi B. Parmar, Heli H. Desai, ...
Related Articles
Unlocking the Power of Nature: A Comprehensive Review of Herbal Face Serums...
Sweta Joshi, Hricha Joshi, Priyanka, Shaurya Kamal, ...
Hepatoprotective Role of Flavonoids from Ocimum Sanctum Against Halothane Induce...
Suddagoni Santhosh, Narsapuram Bharathi, Thalla Likesh Goud, Gunisetti Sri Anjali, Pitla Maheshwari,...
Formulation and Evaluation of Sustained Release Tablet of an AntiDiabetic Drug V...
Mayur Gokul Jayswal, Vasudev Sharma, Adnan Siddiqui, Raza Khan, Shaikh Aaqueeb Ahmed, Afsar Shaikh, ...
Exploring the Influence of Cholinergic Modulation on Hippocampal Activity and Me...
Arnab Roy, Ankita Singh, Mahesh Kumar Yadav, Indrajeet Kumar Mahto, Chandan Bauri, Rajan Kumar Mahto...
More related articles
Review On : Orphan Diseases And Treatment...
Shweta P. Manapure, Jayshree R. Khade, Vaibhav P. Uplanchiwar, Vinod M. Thakare, Tamanna B. Barve, ...
Basic Chemistry,Mode Of Action And Clinical Uses Of Co Trimoxazole...
Prashant Dattatray waghchaure , Trupti Thange, Vishal Gaikwad, ...
Review On : Orphan Diseases And Treatment...
Shweta P. Manapure, Jayshree R. Khade, Vaibhav P. Uplanchiwar, Vinod M. Thakare, Tamanna B. Barve, ...
Basic Chemistry,Mode Of Action And Clinical Uses Of Co Trimoxazole...
Prashant Dattatray waghchaure , Trupti Thange, Vishal Gaikwad, ...